1-4 of 4
John Yarnold
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Patients with a High Polygenic Risk of Breast Cancer do not have An Increased Risk of Radiotherapy Toxicity

Leila Dorling, Gillian C. Barnett, Kyriaki Michailidou, Charlotte E. Coles, Neil G. Burnet, John Yarnold, Rebecca M. Elliott, Alison M. Dunning, Paul D.P. Pharoah, Catharine M. West
Journal: Clinical Cancer Research
Clin Cancer Res (2016) 22 (6): 1413–1420.
https://doi.org/10.1158/1078-0432.CCR-15-1080
Published: 14 March 2016
View article titled, Patients with a High Polygenic Risk of Breast Cancer do not have An Increased Risk of Radiotherapy Toxicity
Open the PDF for Patients with a High Polygenic Risk of Breast Cancer do not have An Increased Risk of Radiotherapy Toxicity in another window
Includes: Supplementary data
Journal Articles

The Relationship Between Homologous Recombination Repair and the Sensitivity of Human Epidermis to the Size of Daily Doses Over a 5-Week Course of Breast Radiotherapy

Navita Somaiah, John Yarnold, Frances Daley, Ann Pearson, Lone Gothard, Kai Rothkamm, Thomas Helleday
Journal: Clinical Cancer Research
Clin Cancer Res (2012) 18 (19): 5479–5488.
https://doi.org/10.1158/1078-0432.CCR-10-3297
Published: 30 September 2012
View article titled, The Relationship Between Homologous Recombination Repair and the Sensitivity of Human Epidermis to the Size of Daily Doses Over a 5-Week Course of Breast Radiotherapy
Open the PDF for The Relationship Between Homologous Recombination Repair and the Sensitivity of Human Epidermis to the Size of Daily Doses Over a 5-Week Course of Breast Radiotherapy in another window
Includes: Supplementary data
Journal Articles

Late Toxicity Is Not Increased in BRCA1/BRCA2 Mutation Carriers Undergoing Breast Radiotherapy in the United Kingdom

Susan Shanley, Kate McReynolds, Audrey Ardern-Jones, Roger Ahern, Indrajit Fernando, John Yarnold, Gareth Evans, Diana Eccles, Shirley Hodgson, Sue Ashley, Linda Ashcroft, Andrew Tutt, Elizabeth Bancroft, Susan Short, Gerald Gui, The Breast Unit of the Royal Marsden NHS Foundation Trust, Lester Barr, Andrew Baildam, Anthony Howell, Gavin Royle, Lori Pierce, Douglas Easton, Rosalind Eeles
Journal: Clinical Cancer Research
Clin Cancer Res (2006) 12 (23): 7025–7032.
https://doi.org/10.1158/1078-0432.CCR-06-1244
Published: 04 December 2006
View article titled, Late Toxicity Is Not Increased in <em>BRCA1/BRCA2</em> Mutation Carriers Undergoing Breast Radiotherapy in the United Kingdom
Open the PDF for Late Toxicity Is Not Increased in <em>BRCA1/BRCA2</em> Mutation Carriers Undergoing Breast Radiotherapy in the United Kingdom in another window
Journal Articles

Acute Chemotherapy–Related Toxicity Is Not Increased in BRCA1 and BRCA2 Mutation Carriers Treated for Breast Cancer in the United Kingdom

Susan Shanley, Kate McReynolds, Audrey Ardern-Jones, Roger Ahern, Indrajit Fernando, John Yarnold, Gareth Evans, Diana Eccles, Shirley Hodgson, Sue Ashley, Linda Ashcroft, Andrew Tutt, Elizabeth Bancroft, Susan Short, Ian Smith, Gerald Gui, The Breast Unit of the Royal Marsden NHS Foundation Trust, Lester Barr, Andrew Baildam, Anthony Howell, Gavin Royle, Lori Pierce, Douglas Easton, Rosalind Eeles
Journal: Clinical Cancer Research
Clin Cancer Res (2006) 12 (23): 7033–7038.
https://doi.org/10.1158/1078-0432.CCR-06-1246
Published: 04 December 2006
View article titled, Acute Chemotherapy–Related Toxicity Is Not Increased in <em>BRCA1</em> and <em>BRCA2</em> Mutation Carriers Treated for Breast Cancer in the United Kingdom
Open the PDF for Acute Chemotherapy–Related Toxicity Is Not Increased in <em>BRCA1</em> and <em>BRCA2</em> Mutation Carriers Treated for Breast Cancer in the United Kingdom in another window